title: Urinary Mycobacterium szulgai infection in an immunocompetent patient.
abstract: Mycobacterium szulgai is one of the nontuberculous mycobacteria (NTM) and rarely causes diseases in human beings, particularly in immunocompetent patients. Less than 1% of all cases of NTM infection are caused by M szulgai, but the incidence is continuously increasing. Although extrapulmonary infections have been reported, most M szulgai infections are associated with pulmonary diseases. However, to our knowledge, a urinary tract infection caused by M szulgai has never before been reported. Here we report an immunocompetent female who experienced a urinary tract infection caused by M szulgai and was successfully treated with 4 months of isoniazid, rifampin, and levofloxacin.
authors: Department of Infectious Diseases and Clinical Pathology, E-Da Hospital/I-Shou University, Kaohsiung, Taiwan.
authors: Jiun-Nong
authors: JN
authors: Lin
authors: Chung-Hsu
authors: CH
authors: Lai
authors: Yen-Hsu
authors: YH
authors: Chen
authors: Chun-Kai
authors: CK
authors: Huang
authors: Hsiu-Fang
authors: HF
authors: Lin
authors: Hock-Liew
authors: HL
authors: Eng
authors: Hsi-Hsun
authors: HH
authors: Lin
mesh_terms: D000995:Antitubercular Agents / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007121:Immunocompetence; D007538:Isoniazid / Q000627:therapeutic use; D064704:Levofloxacin; D008875:Middle Aged; D009165:Mycobacterium Infections, Nontuberculous / Q000175:diagnosis* / Q000188:drug therapy / Q000276:immunology; D009170:Nontuberculous Mycobacteria / Q000302:isolation & purification; D015242:Ofloxacin / Q000627:therapeutic use; D012293:Rifampin / Q000627:therapeutic use; D014552:Urinary Tract Infections / Q000175:diagnosis* / Q000188:drug therapy / Q000276:immunology
chemical_list: D000995:Antitubercular Agents; D064704:Levofloxacin; D015242:Ofloxacin; D007538:Isoniazid; D012293:Rifampin